Frijol adzuki

Adzuki Bean (Vigna angularis): A Comprehensive Reference

1. Identity and Botanical Classification

1.1 Nomenclature and Taxonomy

The adzuki bean (Vigna angularis), also called red bean, is a legume of the Fabaceae (Leguminosae) family. Its full binomial scientific name, as used in phytochemical literature, is Vigna angularis (Willd.) Ohwi et Ohashi, a kind of traditional legume food also known as red beans or adzuki beans, which is native to China. The species epithet angularis derives from Latin, indicating the angular shape of the bean.

The bean carries a variety of common and regional names reflecting its cultural centrality across East Asia. In Chinese, the bean is known as xiaodou (小豆), literally "small bean," a term appearing in ancient texts like the Zhouli (Rites of Zhou) around 300 BCE, contrasting with the soybean's designation as dadou ("big bean"). Alternative Chinese names include hongdou (紅豆) and chidou (赤豆), both meaning "red bean," reflecting its color and cultural prominence in East Asian cuisine and medicine. In Korean, it is called pat (팥), a term used since ancient times for this staple in traditional sweets and porridges. The Japanese romanization is commonly rendered as azuki, and the English term "adzuki" is a phonetic adaptation from Japanese.

1.2 Plant Description and Natural Source

The adzuki bean plant is an annual forage plant that can reach heights of 60 to 80 centimeters (about 24 to 31 inches). It features slender stems that climb and often require support. The leaves are trifoliate, with each leaf being oval to heart-shaped. The adzuki bean plant grows about 12–30 inches tall and produces pods, each containing three to ten primarily dark red seeds with a white ridge on the side.

The plant is native to East Asia and may have been independently domesticated in Korea, Japan, and China. Adzuki beans are grown all over the world, including Africa, Europe, and the Americas, with Asia having the largest area of adzuki beans. It is planted in more than 30 countries and regions, of which China has the largest production. Adzuki bean has become the sixth-largest crop in Japan.

1.3 Common Preparations and Dosage Forms

Adzuki beans are prepared and consumed in a wide variety of forms across culinary and supplement contexts. The dried beans are commonly soaked and then boiled for use in a wide variety of dishes. Adzuki beans with sticky rice, known as sekihan, is traditionally served on festive occasions in Japan. Dried beans are often processed into a starchy flour used in cakes, confections, porridge, or soups. Sweetened adzuki paste, commonly known as red bean paste, is a popular ingredient in many Asian desserts, including ice cream, shaved ice, dumplings, and sweet adzuki bean soup as well as mooncakes, bao, mochi, and numerous other pastries.

Adzuki bean flour is mixed with wheat flour to make noodles. Beans also may be popped like popcorn, used as a beverage base, or used as a coffee substitute. In the United States, people often consume sprouts of germinated seeds. In China, adzuki bean sprouts are consumed as food and herbal medicine.

In the dietary supplement and functional food market, adzuki bean is available as a whole dried bean, canned cooked bean, flour, powdered extract, concentrated polyphenol extract (derived from the boiling water produced during paste preparation), and in extruded food forms such as vermicelli and instant powders. One commercial form — "adzuki bean extract" — has been developed from the released water obtained during adzuki bean paste production.

2. Traditional and Historical Use

2.1 Traditional Chinese Medicine

Adzuki bean is mainly produced and consumed in China and several other countries in East Asia. It has been used as traditional Chinese herbal medicine and food for over thousands of years. Widely consumed in East Asia, adzuki bean has approximately 2,000 years of cultivation history and culinary use. According to the Chinese pharmacopoeia, adzuki bean can be used in the treatment of diuresis, swelling, and abscesses.

The practice of "eating beans to lose weight" has been documented since the Tang Dynasty of China; this folk practice remains popular in China, Japan, and South Korea. As an herbal medicine, adzuki bean has been practiced since the Tang Dynasty of China to maintain health and control weight. In traditional Chinese medicine (TCM), adzuki beans are believed to support kidney function and aid in detoxification.

2.2 Japanese and Korean Traditional Use

In Japanese folk medicine, adzuki beans were often consumed as a restorative food, believed to purify the blood and strengthen the spleen. Healers would prepare soothing broths or sweet pastes from the beans for those suffering from edema or to support convalescence. Adzuki beans are known to have originated in China where they are used extensively in traditional medicine. They are a staple in the macrobiotic diet and very popular in Japan, second only to the soybean in terms of consumption and popularity.

Macrobiotic principles, which draw from Buddhist philosophy and traditional Eastern medicine, consider adzuki beans to be uniquely balanced. Gentle, grounding, and nourishing, they are considered the most warming of all beans, and thus ideal for healing and gaining strength. Unlike other beans, which can be heavy, gassy, or overly yin (cold and expansive), adzuki are seen as the most energetically balanced legume.

2.3 Pharmacopeial Recognition

Adzuki beans are regarded as an ethnopharmacologically well-known folk medicine in Korea, China, and Japan. The Chinese pharmacopoeia formally recognizes adzuki bean as a medicinal food ingredient, particularly for edema, diuresis, and skin abscesses.

3. Nutritional Composition

3.1 Macronutrients

Different nutritional parameters were analyzed for 100 g of edible portion of dried seed and the results were as follows: water, 15%; energy, 324 kcal; protein, 21.1 g; fat, 1.0 g; carbohydrate, 59.5 g; fiber, 3.9 g; ash, 3.4 g; calcium, 82 mg; iron, 6.4 mg; thiamine, 0.45 mg; riboflavin, 0.15 mg; and niacin, 2.2 mg. These values reflect a general profile; significant genotype-level variation exists. The variability range among different traits across 100 diverse accessions was as follows: moisture: 7.5–13.3 g/100 g, ash: 1.8–4.2 g/100 g, protein: 18.0–23.9 g/100 g, starch: 31.0–43.9 g/100 g, total soluble sugar: 3.0–8.2 g/100 g, phytic acid: 0.65–1.43 g/100 g, phenol: 0.01–0.59 g/100 g, antioxidant: 11.4–19.7 mg/100 g GAE.

Adzuki beans are rich in starch, and their proteins contain a balanced variety of amino acids with high lysine content, making up for the lack of protein content of cereals in the daily diet. The kernels are also rich in iron, calcium, phosphorus, vitamin B1, and vitamin B2, among other minerals, as well as containing eight essential amino acids for the human body.

3.2 Lipid Composition

The lipid fraction has a good amount of unsaturated essential fatty acids and has low amounts of saturated fatty acids. A study of 17 Chinese adzuki bean varieties found that palmitic acid (27.68%), linoleic acid (33.11%) and linolenic acid (26.61%) were the dominant fatty acids.

3.3 Starch and Glycemic Properties

Adzuki beans have a high content of resistant starch, which accounts for about 23.57% of total starch, and have suitable amino acid constitutions. A study on four adzuki bean varieties found that these adzuki beans, containing numerous phenolics, showed inhibitory activities to alpha-amylase, with α-AI activities between 1.760 ± 0.044 and 3.411 ± 0.186 U/g. The resistant starch (RS) contributed predominantly to the total starch with proportions between 69.78 ± 2.45% and 81.03 ± 0.06%. The adzuki beans were categorized into low- or medium-GI foods, and the in vitro glycemic index (IVGI) ranged from 39.00 ± 0.36 to 56.76 ± 4.21.

Processing method significantly influences glycemic response. The estimated glycemic index (eGI) value of adzuki bean powder prepared by steamed cooking (SC), extruded cooking (EC), and roller cooking (RC) was studied comparatively. Results showed that RC had the highest eGI, with 80.1, and both EC and SC resulted in lower eGI values of 70.0 and 49.7, respectively. Compared with the EC and RC methods, the SC method provided a more intact physical barrier for starch digestion, resulting in a less destroyed cell structure.

4. Key Bioactive Compounds and Mechanisms of Action

4.1 Polyphenols: Flavonoids

A total of 15 compounds from adzuki bean were identified by HPLC–DAD–ESI–MSⁿ. Among these 15 compounds identified, four flavonoids (catechin, vitexin-4″-O-glucoside, quercetin-3-O-glucoside, and quercetin-3-O-rutinoside) and six saponins (azukisaponin I, II, III, IV, V, and VI) in adzuki bean were further quantified. Additional phenolic acids identified in adzuki bean ethanol extracts include gallic acid, catechin, ferulic acid, and hesperidin. Adzuki beans contain catechin, protocatechin, gallic acid, chlorogenic acid, rutin, and quercetin glycosides.

Studies have indicated that polyphenols extracted from the seed coats of adzuki beans exhibit superior scavenging abilities for free radicals compared to vitamin C. All studied adzuki bean varieties possessed strong ABTS·+ free-radical-scavenging capacity and α-glucosidase inhibition activity. Significant positive correlations (p < 0.01) of the antioxidant activity with total phenolic acids, total flavonoids, and free caffeic acid contents were observed.

4.2 Saponins

Six oleanane-type triterpene oligoglycosides named adzukisaponins (I through VI) were identified in the ethanolic extracts of the red beans by HPLC–DAD–ESI–MS analysis. These adzuki-specific saponins represent a structurally distinct class of bioactive compounds. Most of the isolated saponins reported an inhibition of nitric oxide (NO) production, which has been correlated with the anti-obesity mechanism. Adzukisaponin VI, adzukisaponin IV, and angulasaponins B and C were identified as among the best compounds in enzymatic binding analyses.

4.3 Polysaccharides

Polysaccharides are one of the main biologically active substances of beans. Adzuki bean polysaccharides are reported to significantly reverse insulin resistance and dyslipidemia in diabetic rats. Polysaccharides also exhibit prebiotic effects, influencing the composition of gut microbiota.

4.4 Anthocyanins

The main phytochemicals in adzuki beans include procyanidins, anthocyanins, saponins, flavonoids, flavones, and tannins. Anthocyanin content varies markedly by seed coat color: black-coated varieties have substantially higher anthocyanin levels than standard red varieties. Anthocyanin was identified as a major contributor to α-glucosidase inhibition, as black adzuki beans had higher anthocyanin contents. A study found neuroprotective potential in these pigments: a recent study suggested that adzuki bean extract may inhibit the formation of β-amyloid plaques and prevent the development of Alzheimer's disease, with this neuroprotective effect likely arising from the well-known anti-oxidative and anti-neurodegenerative effects of polyphenols.

4.5 Bioactive Peptides and Proteins

The adzuki bean is abundant in carbohydrates, proteins, and bioactive compounds such as polysaccharides, polyphenols, flavonoids, saponins, and peptides. A 2025 study in Molecular Nutrition & Food Research investigated the antidiabetic potential of adzuki bean β-vignin peptides in human liver cells in healthy and insulin-resistant states.

4.6 Summary of Established Mechanisms

• α-Glucosidase inhibition: Flavonoids, saponins, and whole bean extracts have been shown to inhibit α-glucosidase in vitro, slowing the breakdown of dietary carbohydrates and thereby attenuating post-meal glucose rise. α-glucosidase activity assays showed that adzuki bean flavonoids, saponins, and total extract all had a dose-dependent inhibitory effect on α-glucosidase.
• Pancreatic lipase inhibition: Inhibitory effects of flavonoids and saponins from adzuki bean on pancreatic lipase activity were assessed in vitro, suggesting reduced dietary fat absorption as a mechanism underlying anti-obesity effects.
• Lipolysis enhancement: Adzuki bean extracts enhanced lipolysis in isolated fat cells, providing a further mechanism for body-fat reduction in preclinical models.
• Nitric oxide synthase modulation: Adzuki bean extract (ABE) reduced elevated blood pressure and increased NO production in long-term treatment. This may be associated with the modulation of eNOS and iNOS protein expressions in the aorta and kidney during the development of hypertension.
• Renin-angiotensin system modulation: Adzuki bean ethanol extracts were evaluated for their antihypertensive effects on blood pressure, renin-angiotensin system (RAS), and aortic lesion in spontaneously hypertensive rats.
• Hepatic lipid metabolism regulation: Adzuki bean powder ameliorated hepatic lipogenesis by inhibiting SREBP-1c and FAS mRNA expression and increased hepatic β-oxidation by increasing PPARα and CPT-1 mRNA expression.
• Gut microbiota modulation: Adzuki beans exhibit the ability to modulate gut microbiota by promoting beneficial bacteria like Akkermansia, which enhance insulin sensitivity and lipid metabolism.
• Free-radical scavenging: Adzuki beans possess free-radical scavenging abilities including against DPPH, ferric-ion-reducing antioxidant power (FRAP), O₂⁻·, ABTS⁺, and ·OH.

5. Scientific Evidence by Area of Use

5.1 Type 2 Diabetes and Glycemic Control

Human Clinical Evidence

To date, only one human study, thirteen animal studies, and two in vitro studies have investigated the antidiabetic potential of the adzuki bean. The sole human trial was a randomized controlled design: a parallel, randomized, open-label, controlled trial was designed to evaluate the changes in glucose metabolism indicators and inflammatory markers among T2DM patients following a 4-week extruded adzuki bean convenient food (EABCF) intervention compared to a traditional low glycemic index (LGI) diet. From January to February 2016, type 2 diabetic patients were recruited from the endocrinology clinic of the Pinggu Hospital of Traditional Chinese Medicine (Beijing, China). In a randomized controlled trial, 120 T2DM patients were randomly assigned to a control diet group (the LGI group, assigned the traditional diabetic low glycemic index diet) or an intervention group (the EABCF group, assigned daily consumption of EABCF). Diet information and blood samples were collected at baseline and after a 4-week intervention. After excluding exogenous insulin users, a subgroup analysis based on baseline fasting insulin levels was conducted, and the Homeostasis Model Assessment (HOMA) was the target indicator. A total of 106 patients completed the trial, and 89 participants were included in the subgroup analysis.

Participants were provided 44.8 g of adzuki bean extract per day in the form of extruded adzuki bean convenience food (vermicelli, instant powder, and hard candy) during the four-week intervention period. Liu et al. found no significant difference in fasting blood glucose, HbA1C, glycated albumin, fasting insulin, and insulin resistance index of the study participants who consumed the traditional diabetic low-glycemic-index diet and those who consumed an extruded adzuki bean convenience food (p > 0.05). EABCF had a similar hypoglycemic effect as the traditional diabetic LGI diet and showed a greater inhibitory effect on inflammation in T2DM patients.

Evidence strength: Based on the existing scientific literature, the effects of adzuki bean consumption on preventing and managing type 2 diabetes in humans remain undetermined. Consequently, human randomized controlled trials are needed to elucidate the potential benefits of the adzuki bean and its bioactive components in the prevention and management of T2D. The existing body of evidence is heavily skewed toward animal and in vitro data; only one human RCT has been conducted to date.

Animal Evidence

Out of 13 animal studies, all 13 showed that experimental animals who received adzuki bean treatments revealed improvements in T2D indicators such as blood glucose levels, insulin sensitivity, and glucose tolerance. Previous research indicated that 30% adzuki bean supplementation can significantly decrease serum glucose, LDL-C, and total cholesterol levels, and improve the glucose tolerance of mice with diabetes induced by a high-fat diet combined with streptozotocin.

5.2 Obesity and Lipid Metabolism

Animal and In Vitro Evidence

A high-fat-diet-induced obesity model was created to study anti-obesity effects of adzuki bean. Both serum and liver lipid parameters were determined after 8 weeks of intervention. Total extract, flavonoids, and saponins from adzuki bean could decrease body weight, adipose tissue weights, serum TG, TC, and LDL-C, and liver lipids of mice fed with a high-fat diet while increasing serum HDL-C by oral administration. The study authors acknowledged a key limitation: the crude extracts were used because there were not enough amounts of isolated and purified compounds from adzuki bean for the animal study.

A separate murine study at the whole-bean level found that mice were fed a low-fat diet, a high-fat diet (HFD), and an HFD supplemented with 15% adzuki bean for 12 weeks. Adzuki bean supplementation significantly reduced obesity, lipid accumulation, and serum lipid and lipopolysaccharide (LPS) levels induced by HFD. It also mitigated liver function damage and hepatic steatosis. In particular, adzuki bean supplementation improved glucose homeostasis by increasing insulin sensitivity. In addition, it significantly reversed HFD-induced gut microbiota imbalances.

In an in vitro adipocyte study, treating human adipocytes with 250 µg/mL, 500 µg/mL, or 750 µg/mL adzuki bean polymerized polyphenols or unpolymerized polyphenols significantly lowered the triglyceride (TG) concentration in the adipocytes (p < 0.05). Only cells treated with adzuki bean unpolymerized polyphenols showed a dose-dependent effect.

Human Evidence

The safety and efficacy of polyphenol-containing adzuki bean extract on lipid metabolism were evaluated in human subjects in an 8-week, randomized, double-blind, placebo-controlled, parallel intervention study. The adzuki bean group showed a significant increase in the ΔHDL-C concentration compared with the placebo group after 4 weeks of intervention (3.76 ± 7.79 mg/dL vs. −0.08 ± 6.03 mg/dL, respectively). This short-term study represents the first step in establishing the practicality, safety, and plausibility of HDL-C maintaining effects of adzuki bean extract in human subjects. The study's authors characterize it as preliminary, and the number of participants and study duration limit its generalizability.

Evidence strength: Overall evidence for anti-obesity and lipid-lowering effects is preliminary in humans, with consistent preclinical findings from animal models but very limited human interventional data.

5.3 Antioxidant Activity

Wang et al. compared the antioxidative capacity of four different foods, including dry adzuki bean, fresh raspberry, dry soybean, and fresh broccoli. They found that dry adzuki bean had the lowest EC50 value for DPPH and the highest oxygen radical absorbance capacity among all four foods. Tocopherols and flavonoids, important antioxidant compounds present in adzuki beans, contribute to lowering the risk of cancer, type 2 diabetes, and heart disease, highlighting their nutritional importance.

Evidence strength: Antioxidant capacity of adzuki bean preparations has been robustly demonstrated in laboratory assays using multiple validated methods (DPPH, FRAP, ABTS, ORAC). However, whether these in vitro results translate to meaningful in vivo antioxidant protection in humans has not been established in clinical trials.

5.4 Cardiovascular Health and Blood Pressure

In a preclinical study using spontaneously hypertensive rats (SHR), the antihypertensive effects of adzuki bean ethanol extracts were evaluated on blood pressure, the renin-angiotensin system (RAS), and aortic lesion. A group of SHR were administered 250 and 500 mg/kg of adzuki bean extracts for eight weeks. Both doses of adzuki bean extracts significantly (p < 0.05) reduced relative liver weight, AST, ALT, triglyceride, total cholesterol, systolic blood pressure, and angiotensin-converting-enzyme level compared to the SHR control.

Adzuki bean extract may reduce the elevation of blood pressure by regulating endothelial nitric oxide synthase (eNOS) and inducible nitric oxide synthase (iNOS) protein expression in the aorta and kidney.

Evidence strength: All cardiovascular evidence to date is from animal models. No human clinical trials have specifically examined blood pressure outcomes. Evidence is therefore preliminary and mechanistically suggestive only.

5.5 Gut Microbiota and Digestive Health

Adzuki bean supplementation significantly reduced the ratio of Firmicutes/Bacteroidetes (F/B) and enriched the occurrence of beneficial bacteria including Bifidobacterium, Prevotellaceae, Ruminococcus_1, and others while returning HFD-dependent taxa toward baseline levels in mice. Notably, adzuki beans exhibit unique functional properties, such as high resistant starch content and the ability to modulate gut microbiota by promoting beneficial bacteria like Akkermansia, which enhance insulin sensitivity and lipid metabolism.

Black adzuki beans can also attenuate colon inflammation by improving mucosal barrier protection, reducing endotoxemia, and decreasing inflammatory cytokines.

Evidence strength: Gut microbiota effects are supported by animal studies. No dedicated human clinical trials have assessed adzuki bean consumption specifically for gut microbiome outcomes.

5.6 Liver Protection

Adzuki bean powder ameliorated hepatic lipogenesis by inhibiting SREBP-1c and FAS mRNA expression and increased hepatic β-oxidation by increasing PPARα and CPT-1 mRNA expression with a decrement of liver weight in non-alcoholic fatty liver disease mice. Adzuki bean supplementation significantly reduced obesity, lipid accumulation, and serum lipid and lipopolysaccharide (LPS) levels induced by HFD. It also mitigated liver function damage and hepatic steatosis in mice.

Evidence strength: Hepatoprotective effects are demonstrated only in animal models, with no direct human trial evidence.

5.7 Neuroprotective Effects

Adzuki bean ethanolic extracts have been reported to attenuate angiogenesis, diabetes, osteoporosis, muscle atrophy, and allergic inflammation, as well as delay in the progression of Alzheimer's disease in experimental models. High-fat-diet-induced obesity has been associated with cognitive and memory dysfunction. Studies have confirmed the contribution of adzuki beans to the treatment of obesity-induced cognitive decline.

Catechin, rutin, and quercetin-3-glucoside were found in highest abundance in adzuki bean seedcoats, which also showed acetylcholinesterase inhibitory activity in Australian adzuki bean genotypes.

Evidence strength: Neuroprotective effects are based entirely on animal models and in vitro studies. No human trials have been conducted.

5.8 Germination and Processing Effects on Bioavailability

During germination treatment, the in vitro protein digestibility of adzuki beans increased by 10.98%. There was an increase in the antioxidant activity of adzuki beans by 71.14% after 72 hours of germination. The reducing power assay of adzuki beans indicated an increase of 36.42% during germination. Similarly, the flavonoid and metal chelating activity increased in adzuki beans after 72 hours of germination. In contrast, anti-nutrients such as phytic acid, tannin content, and trypsin inhibitor activity decreased significantly (p < 0.05) after 72 hours of germination.

6. Body Systems and Health Areas Associated with Adzuki Bean

• Metabolic / Endocrine System: Blood glucose regulation, insulin sensitivity, type 2 diabetes management (preliminary human evidence; robust animal evidence).
• Cardiovascular System: Lipid profile improvement (HDL-C, LDL-C, TG, TC), blood pressure attenuation via eNOS/iNOS and renin-angiotensin system modulation (animal evidence; one human lipid RCT).
• Gastrointestinal System: Dietary fiber and resistant starch supporting gut motility; modulation of gut microbiota composition (animal evidence).
• Hepatic System: Inhibition of hepatic lipogenesis, promotion of β-oxidation, protection against non-alcoholic fatty liver disease markers (animal evidence).
• Nervous System: Preliminary evidence of β-amyloid inhibition and acetylcholinesterase inhibitory activity relevant to Alzheimer's disease (in vitro and animal evidence).
• Musculoskeletal System: Red bean extract increased grip strength, exercise endurance, muscle weight, and muscle fiber area, and could significantly decrease the mRNA expression of proteolytic-related genes in animal studies.
• Renal System: Historically used as a diuretic in TCM; adzuki bean extracts have been studied for protection against diabetes-induced kidney disease in animal models.
• Immune/Inflammatory System: Anti-inflammatory effects attributed to saponins and flavonoids, demonstrated in cell and animal models.

7. Dosages Reported in Studies

No universally established therapeutic dosage exists for adzuki bean or its extracts. The following dosages have been reported in specific research contexts:

• Human RCT (type 2 diabetes): 44.8 g of adzuki bean extract per day in the form of extruded adzuki bean convenience food (vermicelli, instant powder, and hard candy) administered during a four-week intervention period.
• Human RCT (lipid metabolism): An 8-week, randomized, double-blind, placebo-controlled, parallel intervention study using polyphenol-containing adzuki bean extract. Specific daily extract dose was not detailed in the available abstract.
• Animal (hypertension): Spontaneously hypertensive rats were administered 250 and 500 mg/kg of adzuki bean extracts for eight weeks.
• Animal (obesity, whole bean): Mice were fed an HFD supplemented with 15% adzuki bean for 12 weeks.
• Animal (obesity, extract): Rats receiving 1% adzuki bean extract and a high-fat diet had a significantly lower serum non-HDL level after 4 weeks of treatment compared to their control counterparts (p < 0.05).
• In vitro (adipocytes): Human adipocytes were treated with 250 µg/mL, 500 µg/mL, or 750 µg/mL adzuki bean polymerized polyphenols or unpolymerized polyphenols.

8. Safety Considerations

8.1 General Safety

No adverse effects were observed in the participants receiving adzuki bean extract in the 8-week human lipid study, suggesting a reasonable short-term safety profile at the doses studied. The Vigna angularis seed flour is suggested to be relatively safe for consumption based on phytochemical screening data.

8.2 Antinutritional Factors

The primary antinutrients found in adzuki beans are phytates, α-galactosides, and trypsin inhibitors. Phytates can decrease the absorption of iron, zinc, magnesium, and calcium. The trypsin inhibitors can worsen the breakdown and subsequent absorption of proteins. Both lima and adzuki beans contain various anti-nutrients like phytic acid, tannins, trypsin inhibitors, oxalate, haematoglutinins, and cyanides, which interfere with the utilization and absorption of numerous micronutrients, thereby decreasing the nutritive value and protein digestibility of foods.

These antinutrients can be substantially reduced by processing: most of the antinutrients can be removed or deactivated by soaking, sprouting, or cooking the beans. Specifically, germination for 72 hours was associated with significant decreases in phytic acid, tannins, and trypsin inhibitor activity.

8.3 Oxalate Content and Kidney Stones

Adzuki beans contain 25 mg of oxalates; therefore, their consumption should be limited for people at risk of kidney stones. This amount of oxalic acid is considered low for most people but high for people at risk of developing calcium oxalate kidney stones. Consequently, adzuki bean consumption should be limited for people at risk.

8.4 Allergy

Cases of adzuki bean allergy have been reported. However, it is extremely rare and underresearched. Cross-reactivity with other legumes, as seen with other members of the Fabaceae family, is a theoretical concern but has not been specifically studied in detail for adzuki bean.

8.5 Estrogen-Like Activity and Breast Cancer Risk

Despite the numerous beneficial cancer-preventive effects of adzuki beans, they may have a negative effect on estrogen receptor-positive (ER+) breast cancer. Ethanol extract of adzuki beans has been studied to have estrogen-like activities that may stimulate the proliferation of breast cancer cells. This finding, based on cell-culture (in vitro) data, warrants caution and has not been examined in human clinical studies.

8.6 α-Galactosides and Flatulence

Like other legumes, adzuki beans contain α-galactosides, a class of oligosaccharides that are not digested by human intestinal enzymes and are fermented in the colon by resident bacteria, which can lead to gas production and flatulence, particularly in individuals unaccustomed to high legume intake. Soaking and cooking reduce but do not eliminate these compounds.

8.7 Evidence Gaps and Research Limitations

Bioactive components such as phenols and polysaccharides in adzuki beans have been confirmed to play an important role in human health, but there are no relevant standards for the extraction of these substances, resulting in differences in the identification and contents of substances due to differences in extraction methods in the research process. There is still a lack of sufficient scientific basis to explain the scientific principles of the popular folk practice of weight control using adzuki bean. The large majority of evidence for all health benefits beyond basic nutrition remains preclinical, and robust, adequately powered, long-term human clinical trials are absent across nearly all proposed health areas.

References

• Padhi S et al. "The Potential of the Adzuki Bean (Vigna angularis) and Its Bioactive Compounds in Managing Type 2 Diabetes and Glucose Metabolism: A Narrative Review." PMC / Nutrients, 2024.
• Liu Y et al. "Convenient food made of extruded adzuki bean attenuates inflammation and improves glycemic control in patients with type 2 diabetes: a randomized controlled trial." PMC / Therapeutics and Clinical Risk Management, 2018.
• Liu Y et al. "Saponins and Flavonoids from Adzuki Bean (Vigna angularis L.) Ameliorate High-Fat Diet-Induced Obesity in ICR Mice." PMC / Frontiers in Pharmacology, 2017.
• Liu Y et al. "Characterization and quantification of flavonoids and saponins in adzuki bean (Vigna angularis L.) by HPLC–DAD–ESI–MSn analysis." PMC, 2017.
• Zhao P et al. "Nutritional Composition, Efficacy, and Processing of Vigna angularis (Adzuki Bean) for the Human Diet: An Overview." PMC, 2022.
• Padhi S et al. "Nutritional Potential of Adzuki Bean Germplasm and Mining Nutri-Dense Accessions through Multivariate Analysis." PMC, 2023.
• Guo Y et al. "Adzuki Bean Alleviates Obesity and Insulin Resistance Induced by a High-Fat Diet and Modulates Gut Microbiota in Mice." PMC, 2021.
• Potential anti-obesity effect of saponin metabolites from adzuki beans: A computational approach. PMC, 2024.
• Park S et al. "Black Soybean and Adzuki Bean Extracts Lower Blood Pressure by Modulating the Renin-Angiotensin System in Spontaneously Hypertensive Rats." PMC, 2021.
• Mukai Y, Sato S. "Polyphenol-containing azuki bean (Vigna angularis) extract attenuates blood pressure elevation and modulates nitric oxide synthase and caveolin-1 expressions in rats with hypertension." PubMed, 2009.
• Kitano-Okada T et al. "Safety and efficacy of adzuki bean extract in subjects with moderate to high LDL-C: a randomized trial." Bioscience, Biotechnology, and Biochemistry, 2019.
• Phenolic profile, alpha-amylase inhibitory activity, and in vitro glycemic index of adzuki beans. PubMed, 2022.
• Effects of Different Processing Methods and Internal Components on Physicochemical Properties and Glycemic Index of Adzuki Bean Powder. PMC, 2021.
• Analysis and Research on Starch Content and Its Processing, Structure and Quality of 12 Adzuki Bean Varieties. PMC, 2022.
• Effects of Soaking and Germination Treatments on the Nutritional, Anti-Nutritional, and Bioactive Characteristics of Adzuki Beans (Vigna angularis L.) and Lima Beans (Phaseolus lunatus L.). PMC / Foods, 2024.
• Yao Y et al. "Nutritional composition and biological activities of 17 Chinese adzuki bean (Vigna angularis) varieties." Food and Agricultural Immunology, 2016.
• Li H et al. "Adzuki bean (Vigna angularis): Chemical compositions, physicochemical properties, health benefits, and food applications." Comprehensive Reviews in Food Science and Food Safety, 2022.
• A Comprehensive Review of the Chemical Constituents and Functional Properties of Adzuki Beans (Vigna angulariz). Journal of Agricultural and Food Chemistry, 2025.
• Phenolic profiles and acetylcholinesterase inhibitory activity in Australian adzuki bean. ScienceDirect, 2023.
• Petruzzello M. "Adzuki bean." Encyclopaedia Britannica.
• Oregon State University Extension Service. "Adzuki Bean: A Potential Rotational Crop for the Columbia Basin."
• Nutritional Composition, Efficacy, and Processing of Vigna angularis (Adzuki Bean) for the Human Diet: An Overview. ResearchGate, 2022.
• Adzuki Beans (Vigna Angularis): Nutritional and Functional Properties. ResearchGate, 2021.
• Nutrient transfer and antioxidant effect of adzuki bean before and after GABA enrichment. PMC, 2023.
• Kwan et al. "Peptides From Adzuki Bean and Soybean Improved Insulin-AKT Signaling-Related Pathways in Healthy and Insulin-Resistant States in Human Liver Cells." Molecular Nutrition & Food Research, 2025.